Macular pigment changes after cataract surgery with yellow-tinted intraocular lens implantation.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2021
2021
Historique:
received:
17
12
2020
accepted:
26
02
2021
entrez:
25
3
2021
pubmed:
26
3
2021
medline:
12
10
2021
Statut:
epublish
Résumé
We previously reported that macular pigment optical density (MPOD) levels decreased during a long follow-up period after clear intraocular lens (IOL) implant surgery presumably due to excessive light exposure. We examined changes in MPOD levels in the eyes that received yellow-tinted IOL implant surgery. This was a prospective, observational study. Fifty-five eyes of 35 patients were studied. MPOD levels were measured with a dual-wavelength autofluorescence technique on day 4; months 1, 3, and 6; and years 1 and 2 postoperatively. The average optical densities at 0°- 2° eccentricities (local MPODs) and total volumes of MPOD (MPOVs) in the area within 1.5° and 9° eccentricities were analyzed. The mean local MPOD at baseline (on day 4) was 0.79 at 0°, 0.71 at 0.5°, 0.68 at 0.9°, and 0.32 at 2°. The mean MPOV within 1.5° and 9° at baseline was 2950 and 18,897, respectively. Local MPOD at 0.9° and 2° and MPOVs were slightly decreased at month 1 and increased after that. The increase reached statistical significance in local MPOD at 0.5° and 2° and MPOVs (Tukey-Kramer test). The changes in MPOV within 9° at year 2 [(MPOV on year 2 - MPOV on day 4) / MPOV on day 4] were from -0.21 to 1.18 (mean and standard deviation: 1.14 ± 0.28). The MPOV of 15 eyes increased more than 10% from the initial value, was maintained within 10% in 21 eyes, and deteriorated more than 10% in only 3 eyes. Local MPOD and MPOV tended to slightly decrease month 1 postoperatively and gradually increased after that, but the rates of increases in MPOD levels were small. Yellow-tinted IOLs that have a lower transmittance of blue light might be preferable for preserving MPOD levels after surgery.
Identifiants
pubmed: 33764992
doi: 10.1371/journal.pone.0248506
pii: PONE-D-20-39598
pmc: PMC7993776
doi:
Substances chimiques
Macular Pigment
0
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0248506Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Eye (Lond). 2019 Aug;33(8):1203-1214
pubmed: 30894692
Int J Mol Sci. 2019 Apr 11;20(7):
pubmed: 30979028
Arch Ophthalmol. 2002 Nov;120(11):1551-8
pubmed: 12427071
Transl Vis Sci Technol. 2019 Dec 18;8(6):41
pubmed: 31867142
Annu Rev Nutr. 2003;23:171-201
pubmed: 12626691
Retin Cases Brief Rep. 2019 Jan 10;:
pubmed: 30640318
Indian J Ophthalmol. 2012 Nov-Dec;60(6):561-3
pubmed: 23202400
Invest Ophthalmol Vis Sci. 1993 May;34(6):2033-40
pubmed: 8491553
Retina. 2016 Apr;36(4):787-90
pubmed: 26441265
J Cataract Refract Surg. 2010 Feb;36(2):299-307
pubmed: 20152614
Exp Eye Res. 2018 Mar;168:100-106
pubmed: 29357284
Optom Vis Sci. 2011 Aug;88(8):1014-9
pubmed: 21552175
Am J Ophthalmol. 2016 Nov;171:88-94
pubmed: 27590121
Br J Ophthalmol. 2008 May;92(5):630-4
pubmed: 18441173
Invest Ophthalmol Vis Sci. 2012 Jun 26;53(7):4076-84
pubmed: 22491402
Case Rep Ophthalmol Med. 2013;2013:906920
pubmed: 23476848
Arch Toxicol. 2019 May;93(5):1401-1415
pubmed: 30778631
Retina. 2016 Jul;36(7):1381-7
pubmed: 26655614
J Photochem Photobiol B. 2001 Nov 15;64(2-3):144-61
pubmed: 11744401
Retina. 2014 Dec;34(12):2388-96
pubmed: 25380069
Surv Ophthalmol. 2008 Jul-Aug;53(4):359-67
pubmed: 18572053
Prog Retin Eye Res. 2016 Jan;50:34-66
pubmed: 26541886
Invest Ophthalmol Vis Sci. 2000 Jun;41(7):1981-9
pubmed: 10845625
Jpn J Ophthalmol. 2011 Jul;55(4):428-430
pubmed: 21633809
Retin Cases Brief Rep. 2011 Summer;5(3):223-6
pubmed: 25390169
Retina. 2012 Feb;32 Suppl 1:28-43
pubmed: 22451949
Invest Ophthalmol Vis Sci. 2018 Jun 1;59(7):3011-3019
pubmed: 30025122
Retin Cases Brief Rep. 2013 Fall;7(4):371-5
pubmed: 25383813
Invest Ophthalmol Vis Sci. 2017 Jul 1;58(9):3616-3627
pubmed: 28728169
Invest Ophthalmol Vis Sci. 2016 May 1;57(6):2552-63
pubmed: 27163768
J Physiol. 1988 Jan;395:577-87
pubmed: 3411488
Acta Ophthalmol Scand. 2006 Feb;84(1):4-15
pubmed: 16445433
Arch Ophthalmol. 2012 Dec;130(12):1540
pubmed: 23229694
Ophthalmology. 2016 Mar;123(3):570
pubmed: 26902564
Eye (Lond). 2019 Mar;33(3):492-504
pubmed: 30546136
Mol Aspects Med. 2005 Dec;26(6):459-516
pubmed: 16309738
Int J Toxicol. 2002 Nov-Dec;21(6):473-90
pubmed: 12537644
J Occup Med. 1983 Mar;25(3):203-10
pubmed: 6842311
Arch Biochem Biophys. 2001 Jan 1;385(1):28-40
pubmed: 11361022
FEBS Lett. 1997 Nov 24;418(1-2):91-7
pubmed: 9414102
Invest Ophthalmol Vis Sci. 2009 Oct;50(10):4777-85
pubmed: 19628740
Photodiagnosis Photodyn Ther. 2017 Jun;18:264-266
pubmed: 28347866
Arch Ophthalmol. 2004 May;122(5):750-7
pubmed: 15136324
BMC Ophthalmol. 2018 Dec 20;18(1):331
pubmed: 30572865
Vision Res. 1987;27(9):1581-7
pubmed: 3445490
Photochem Photobiol. 1979 Apr;29(4):735-43
pubmed: 109869